COMPASS THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $134.5M | $136.4M |
| Jun 2022 | — | $126.9M | $26.2M |
| Sep 2022 | — | $116.1M | $16.5M |
| Dec 2022 | — | $181.6M | $34.9M |
| Mar 2023 | — | $175.3M | $27.0M |
| Jun 2023 | — | $168.3M | $19.3M |
| Sep 2023 | — | $160.0M | $30.4M |
| Dec 2023 | — | $148.5M | $24.2M |
| Mar 2024 | — | $157.1M | $43.5M |
| Jun 2024 | — | $146.1M | $19.4M |
| Sep 2024 | — | $138.4M | $19.4M |
| Dec 2024 | — | $125.2M | $43.5M |
| Mar 2025 | — | $110.3M | $41.0M |
| Jun 2025 | — | $93.2M | $22.9M |
| Sep 2025 | — | $209.6M | $46.2M |
| Dec 2025 | — | $196.8M | $30.6M |
| Mar 2026 | — | $186.5M | $55.2M |
| Jun 2026 | — | $166.0M | $35.5M |